Trials / Completed
CompletedNCT03217409
A Study to Compare Rosuvastatin/Ezetimibe and Rosuvastatin in Patients With Diabetes Mellitus and Hypercholesterolemia
A Multicenter Clinical Trial to Compare the Efficacy and Safety Between Rosuvastatin/Ezetimibe Combination and Monotherapy of Rosuvastatin in Patients With Diabetes Mellitus and Hypercholesterolemia
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 85 (actual)
- Sponsor
- Yuhan Corporation · Industry
- Sex
- All
- Age
- 19 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
A Study to Compare Rosuvastatin/Ezetimibe Combination and Monotherapy in Patients with Diabetes Mellitus and Hypercholesterolemia.
Detailed description
This trial is conducted to compare the efficacy and safety between Rosuvastatin/Ezetimibe combination and Rosuvastatin monotherapy in patients with Diabetes Mellitus and Hypercholesterolemia for 8 weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Rosuvastatin+Ezetimibe | Rosuvastatin 5mg+Ezetimibe 10mg |
| DRUG | Rosuvastatin | Rosuvastatin 5Mg Tablet |
Timeline
- Start date
- 2017-08-10
- Primary completion
- 2019-04-03
- Completion
- 2019-05-23
- First posted
- 2017-07-14
- Last updated
- 2019-09-23
Locations
4 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03217409. Inclusion in this directory is not an endorsement.